Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.

Cecelia R MillerYing HuangAmy S RuppertJadwiga LabanowskaSamantha M JaglowskiKami J MaddocksKerry A RogersSeema BhatAdam S KittaiMichael GreverRosa LapalombellaLynne V AbruzzoNyla A HeeremaJohn C ByrdErin K HertleinJennifer A Woyach

Published in: Leukemia (2021)

Keyphrases

chronic lymphocytic leukemia
newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
patient reported outcomes